FIELD: medicine.
SUBSTANCE: invention refers to medicine, specifically to conjugates of hydroxyalkyl starch and allergen, in which at least one hydroxyalkyl starch is covalent bonded with allergen for hyposensitisation. Conjugates HAS-allergen provide epitope profile comparable to natural, that enables to increase immunotherapy efficiency.
EFFECT: increasing of immunotherapy efficiency.
14 cl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| A CONJUGATE OF HYDROXYALKYL STARCH AND LOW-MOLECULAR SUBSTANCE AND METHOD OF OBTAINING IT | 2003 |
|
RU2327702C2 |
| HYDROXYALKYL STARCH AND G-CSF CONJUGATES | 2004 |
|
RU2370281C2 |
| METHOD OF OBTAINING DERIVATIVES OF HYDROXYALKYL STARCH | 2003 |
|
RU2329274C2 |
| TRANSPORT MEDIATING COLLOIDAL THERAPEUTIC COMPOUNDS | 2009 |
|
RU2519225C2 |
| POLYPEPTIDES TREATED WITH HAS, PARTICULARLY ERYTHROPOIETIN TREATED WITH HAS | 2003 |
|
RU2328505C2 |
| ETHERS OF ALDONIC ACID, METHOD OF OBTAINING THEM AND METHOD OF OBTAINING PHARMACEUTICAL BIOLOGICALLY ACTIVE MATERIALS CONNECTED TO THEIR FREE AMINO GROUPS WITH POLYSACCHARIDES OR DERIVATIVES OF POLYSACCHARIDES | 2003 |
|
RU2330046C2 |
| BONDING PRODUCTS OF AMINATED POLYSACCHARIDES | 2010 |
|
RU2549492C2 |
| CONJUGATES OF HEMOGLOBIN WITH POLYSACCHARIDE | 1999 |
|
RU2225222C2 |
| DNA SEQUENCE AND PREPARING CEREAL CROPS ALLERGEN BY RECOMBINANT METHOD | 2000 |
|
RU2238321C2 |
| METHOD FOR PRODUCTION OF BEE VENOM ALLERGOID FOR CARRYING OUT ALLERGEN-SPECIFIC IMMUNOTHERAPY | 2019 |
|
RU2731509C1 |
